| scholarly article | Q13442814 |
| P50 | author | Anna Vassall | Q78838744 |
| P2093 | author name string | Claudia B Maier | |
| Michelle Remme | |||
| Mariana Siapka | |||
| Carol Dayo Obure | |||
| Karl L Dehne | |||
| P2860 | cites work | Male circumcision at different ages in Rwanda: a cost-effectiveness study | Q21034170 |
| Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement | Q21562278 | ||
| HIV prevention programmes for female sex workers in Andhra Pradesh, India: outputs, cost and efficiency | Q24816879 | ||
| Costs of medical services for patients with HIV/AIDS in Khon Kaen, Thailand | Q50732511 | ||
| Costs of care provided in a university hospital for children exposed to or infected with the HIV/AIDS. | Q51109494 | ||
| Cost-Effectiveness of Using HAART in Prevention of Mother-To-Child Transmission in the DREAM-Project Malawi | Q57951566 | ||
| The Evolving Cost of HIV in South Africa | Q59156354 | ||
| The Cost of Providing HIV/AIDS Counseling and Testing Services in Vietnam | Q88495394 | ||
| Can we systematically review studies that evaluate complex interventions? | Q28475898 | ||
| How much can we gain from improved efficiency? An examination of performance of national HIV/AIDS programs and its determinants in low- and middle-income countries | Q30414583 | ||
| Modelling the impact and cost-effectiveness of the HIV intervention programme amongst commercial sex workers in Ahmedabad, Gujarat, India | Q30480165 | ||
| HIV prevention cost-effectiveness: a systematic review | Q30892555 | ||
| The cost-effectiveness of antiretroviral treatment in Khayelitsha, South Africa--a primary data analysis | Q31082790 | ||
| HIV prevention costs and program scale: data from the PANCEA project in five low and middle-income countries | Q31118706 | ||
| Outputs, cost and efficiency of public sector centres for prevention of mother to child transmission of HIV in Andhra Pradesh, India | Q33317430 | ||
| Outputs and cost of HIV prevention programmes for truck drivers in Andhra Pradesh, India | Q33449065 | ||
| Cost-effectiveness of HIV prevention interventions in Andhra Pradesh state of India | Q33575387 | ||
| Rates of virological failure in patients treated in a home-based versus a facility-based HIV-care model in Jinja, southeast Uganda: a cluster-randomised equivalence trial | Q33590533 | ||
| Costs and outcomes of VCT delivery models in the context of scaling up services in Indonesia | Q33744330 | ||
| Treatment outcomes and cost-effectiveness of shifting management of stable ART patients to nurses in South Africa: an observational cohort | Q33979490 | ||
| Cost-effectiveness of HIV/AIDS interventions in Africa: a systematic review of the evidence | Q34646375 | ||
| Costs of providing care for HIV-infected adults in an urban HIV clinic in Soweto, South Africa | Q34831668 | ||
| The costs and effectiveness of four HIV counseling and testing strategies in Uganda | Q34912202 | ||
| Cost and cost-effectiveness of HIV/AIDS prevention strategies in developing countries: is there an evidence base? | Q35064694 | ||
| Increasing access to HIV counseling and testing through mobile services in Kenya: strategies, utilization, and cost-effectiveness | Q35576230 | ||
| The cost of providing comprehensive HIV treatment in PEPFAR-supported programs | Q35576296 | ||
| The effects of scale on the costs of targeted HIV prevention interventions among female and male sex workers, men who have sex with men and transgenders in India | Q35656683 | ||
| Case management to improve adherence for HIV-infected patients receiving antiretroviral therapy in Ethiopia: a micro-costing study | Q35690109 | ||
| Does scale matter? The costs of HIV-prevention interventions for commercial sex workers in India. | Q35750673 | ||
| Cost effectiveness of facility-based care, home-based care and mobile clinics for provision of antiretroviral therapy in Uganda | Q35834613 | ||
| Costs of scaling up health interventions: a systematic review | Q36028973 | ||
| Estimating the resource needs of scaling-up HIV/AIDS and tuberculosis interventions in sub-Saharan Africa: a systematic review for national policy makers and planners | Q36358537 | ||
| The determinants of HIV treatment costs in resource limited settings | Q36381028 | ||
| The cost of antiretroviral therapy in Haiti | Q36512486 | ||
| Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party | Q36599584 | ||
| The costs of HIV prevention strategies in developing countries | Q36669651 | ||
| Optimising the cost and delivery of HIV counselling and testing services in Kenya and Swaziland. | Q36678386 | ||
| Changing cost of HIV interventions in the context of scaling-up in India | Q36944602 | ||
| Costs of measures to control tuberculosis/HIV in public primary care facilities in Cape Town, South Africa | Q37063602 | ||
| Early loss of HIV-infected patients on potent antiretroviral therapy programmes in lower-income countries | Q37108925 | ||
| Cost estimates of HIV care and treatment with and without anti-retroviral therapy at Arba Minch Hospital in southern Ethiopia | Q37166426 | ||
| Cost analyses of peer health worker and mHealth support interventions for improving AIDS care in Rakai, Uganda | Q37172026 | ||
| Task shifting in HIV/AIDS: opportunities, challenges and proposed actions for sub-Saharan Africa | Q37321155 | ||
| Unit costs for delivery of antiretroviral treatment and prevention of mother-to-child transmission of HIV: a systematic review for low- and middle-income countries. | Q37323399 | ||
| Costing of scaling up HIV/AIDS treatment in Mexico. | Q37350591 | ||
| Prevention of mother-to-child transmission of HIV in Africa: successes and challenges in scaling-up a nevirapine-based program in Lusaka, Zambia | Q37351420 | ||
| Cost effectiveness of couple counselling to enhance infant HIV-1 prevention | Q37396579 | ||
| Feasibility, acceptability and cost of home-based HIV testing in rural Kenya | Q37529898 | ||
| Costs of interventions for AIDS orphans and vulnerable children | Q37920926 | ||
| Integrated delivery of HIV and tuberculosis services in sub-Saharan Africa: a systematic review | Q37950537 | ||
| Costs and efficiency of integrating HIV/AIDS services with other health services: a systematic review of evidence and experience. | Q37967142 | ||
| What is the cost of providing outpatient HIV counseling and testing and antiretroviral therapy services in selected public health facilities in Nigeria? | Q38415011 | ||
| The high cost of second-line antiretroviral therapy for HIV/AIDS in South Africa | Q38432462 | ||
| Cost and efficiency of HIV voluntary counselling and testing centres in Andhra Pradesh, India. | Q38458287 | ||
| Antiretroviral drugs as a public health intervention for pregnant HIV-infected women in rural South Africa: an issue of cost-effectiveness and capacity. | Q38476740 | ||
| High Uptake of Home-Based, District-Wide, HIV Counseling and Testing in Uganda | Q38871439 | ||
| The role of community acceptance over time for costs of HIV and STI prevention interventions: analysis of the Masaka Intervention Trial, Uganda, 1996-1999. | Q38879801 | ||
| Assessing the cost and willingness to pay for voluntary HIV counselling and testing in Kenya | Q39008797 | ||
| The cost-effectiveness of consistent and early intervention of harm reduction for injecting drug users in Bangladesh | Q39036160 | ||
| Comparative costs and cost-effectiveness of behavioural interventions as part of HIV prevention strategies | Q39081471 | ||
| The cost-effectiveness of HIV preventive measures among injecting drug users in Svetlogorsk, Belarus | Q39151868 | ||
| When to initiate highly active antiretroviral therapy in low-resource settings: the Moroccan experience. | Q39190098 | ||
| Controlling HIV in Africa: effectiveness and cost of an intervention in a high-frequency STD transmitter core group | Q39273228 | ||
| The global strategy to eliminate HIV infection in infants and young children: a seven-country assessment of costs and feasibility | Q39292001 | ||
| Cost-effectiveness of voluntary HIV-1 counselling and testing in reducing sexual transmission of HIV-1 in Kenya and Tanzania | Q39501645 | ||
| From trial intervention to scale-up: costs of an adolescent sexual health program in Mwanza, Tanzania | Q39518169 | ||
| The cost-effectiveness of expanding harm reduction activities for injecting drug users in Odessa, Ukraine | Q39559490 | ||
| The cost of a rapid-test VCT clinic in South Africa | Q39745063 | ||
| Cost of a dedicated ART clinic. | Q39818393 | ||
| The outcomes and outpatient costs of different models of antiretroviral treatment delivery in South Africa | Q39853498 | ||
| Clinical and financial burdens of secondary level care in a public sector antiretroviral roll-out setting (G. F. Jooste Hospital). | Q39892618 | ||
| Financial and economic costs of scaling up the provision of HAART to HIV-infected health care workers in KwaZulu-Natal. | Q40343771 | ||
| Costs of HIV/AIDS outpatient services delivered through Zambian public health facilities | Q42679105 | ||
| Cost-effectiveness of maraviroc for antiretroviral treatment-experienced HIV-infected individuals in Mexico | Q42796823 | ||
| Costing universal access of highly active antiretroviral therapy in Benin | Q43932173 | ||
| Preventing mother to child transmission of HIV with highly active antiretroviral treatment in Tanzania--a prospective cost-effectiveness study | Q43941511 | ||
| Towards an improved investment approach for an effective response to HIV/AIDS. | Q44667685 | ||
| Costs and benefits of HAART for patients with HIV in a public hospital in Mexico | Q44925665 | ||
| The cost effectiveness of integrated care for people living with HIV including antiretroviral treatment in a primary health care centre in Bujumbura, Burundi | Q45238075 | ||
| Brief Communication: Economic Comparison of Opportunistic Infection Management With Antiretroviral Treatment in People Living With HIV/AIDS Presenting at an NGO Clinic in Bangalore, India | Q45895726 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | systematic review | Q1504425 |
| P304 | page(s) | 499-511AD | |
| P577 | publication date | 2014-04-01 | |
| P1433 | published in | Bulletin of the World Health Organization | Q2928049 |
| P1476 | title | Is there scope for cost savings and efficiency gains in HIV services? A systematic review of the evidence from low- and middle-income countries | |
| P478 | volume | 92 |
| Q34659438 | Assessing cost and technical efficiency of HIV prevention interventions in sub-Saharan Africa: the ORPHEA study design and methods |
| Q40491916 | Can differentiated care models solve the crisis in HIV treatment financing? Analysis of prospects for 38 countries in sub-Saharan Africa |
| Q64264821 | Challenges of primary healthcare nurses regarding the integration of HIV and AIDS services into primary healthcare in Vhembe district of Limpopo province, South Africa |
| Q36224801 | Cost Effectiveness of Potential ART Adherence Monitoring Interventions in Sub-Saharan Africa |
| Q47134298 | Cost analysis of two community-based HIV testing service modalities led by a Non-Governmental Organization in Cape Town, South Africa |
| Q30830344 | Cost and cost-effectiveness of tuberculosis treatment shortening: a model-based analysis |
| Q33800939 | Cost-effectiveness of Xpert MTB/RIF for tuberculosis diagnosis in South Africa: a real-world cost analysis and economic evaluation. |
| Q91740920 | Cost-per-diagnosis as a metric for monitoring cost-effectiveness of HIV testing programmes in low-income settings in southern Africa: health economic and modelling analysis |
| Q39538523 | Costs along the HTC and PMTCT service cascades: findings from Kenya, Rwanda, South Africa, and Zambia |
| Q37312739 | Costs along the service cascades for HIV testing and counselling and prevention of mother-to-child transmission |
| Q57177522 | Costs and cost-effectiveness of HIV/noncommunicable disease integration in Africa: from theory to practice |
| Q36665407 | Does integration of HIV and SRH services achieve economies of scale and scope in practice? A cost function analysis of the Integra Initiative |
| Q35610490 | Expenditure Analysis of HIV Testing and Counseling Services Using the Cascade Framework in Vietnam |
| Q46323776 | HIV prevention costs and their predictors: evidence from the ORPHEA Project in Kenya. |
| Q42287819 | How to Integrate HIV and Sexual and Reproductive Health Services in Namibia, the Epako Clinic Case Study |
| Q50193754 | Impact of integration of sexual and reproductive health services on consultation duration times: results from the Integra Initiative |
| Q58592735 | Influence of supply-side factors on voluntary medical male circumcision costs in Kenya, Rwanda, South Africa, and Zambia |
| Q41990805 | Large-scale delivery of seasonal malaria chemoprevention to children under 10 in Senegal: an economic analysis |
| Q34278022 | Optimal allocation of resources in female sex worker targeted HIV prevention interventions: model insights from Avahan in South India. |
| Q37352500 | PrEP as a feature in the optimal landscape of combination HIV prevention in sub-Saharan Africa. |
| Q37064741 | Sustainable HIV treatment in Africa through viral-load-informed differentiated care. |
| Q26748845 | Sustaining the future of HIV counselling to reach 90-90-90: a regional country analysis |
| Q47550013 | The City of Johannesburg can end AIDS by 2030: modelling the impact of achieving the Fast-Track targets and what it will take to get there |
| Q48342184 | The Cost-Effectiveness of Integrating HIV Counseling and Testing into Primary Health Care in the Ukraine |
| Q36289789 | The costs of providing antiretroviral therapy services to HIV-infected individuals presenting with advanced HIV disease at public health centres in Dar es Salaam, Tanzania: Findings from a randomised trial evaluating different health care strategies |
| Q51740189 | The global Optima HIV allocative efficiency model: targeting resources in efforts to end AIDS. |
| Q62485947 | The impact and cost-effectiveness of community-based HIV self-testing in sub-Saharan Africa: a health economic and modelling analysis |
| Q64102807 | The per-patient costs of HIV services in South Africa: Systematic review and application in the South African HIV Investment Case |
| Q35746510 | Trends and Determinants of Antiretroviral Therapy Patient Monitoring Practices in Kenya and Uganda |
| Q55356085 | Universal Health Coverage in Francophone Sub-Saharan Africa: Assessment of Global Health Experts' Confidence in Policy Options. |
| Q37248645 | What Determines HIV Prevention Costs at Scale? Evidence from the Avahan Programme in India |
| Q90027507 | What is the cost of integration? Evidence from an integrated health and agriculture project to improve nutrition outcomes in Western Kenya |
Search more.